Not for Granted: Pediatric Immunization Through Experts’ Lens


As the backbone of our modern healthcare systems, vaccines have helped protect eligible people around the world for centuries. But our ability to halt the potential harm caused by infectious disease is inherently tied to the immunization rates maintained by individual communities.
While the development and distribution of vaccines has made great strides, uptake and coverage rates across Europe still fall short of established targets. (NLM) These challenges have been long recognized and studied in underserved communities, but traditional public health models often overlook vaccination equity within established communities of mixed socioeconomic background.
As part of a multi-year collaboration, Pfizer and EIP set out to identify what’s driving variability in vaccination among members of these communities. By gathering perspectives from community health networks, this research aims to inform and help design effective public health strategies that enhance vaccination equity and coverage.
A quantitative, close-ended survey was distributed to pediatric HCPs to shed light on the complexities of pediatric vaccination hesitancy and low uptake rates.
A targeted mapping questionnaire was also distributed to leading experts and academics across multiple countries throughout Europe with the aim of devising strategies and developing materials for HCPs that help close the gaps.
198 responses were received between October 24 and December 15.
Findings revealed a significant problem lies within communities of mixed socioeconomic backgrounds where some individuals follow national immunization guidelines while others do not, even when seeing the same physicians. These individuals are described as “effectively underserved within their own environments.”
The argument parents do not vaccinate their children by conviction is oversimplified – it’s more complicated than that. While both vaccination refusal and adherence issues stem from parental decision-making, the underlying causes are diverse and complex.
Survey respondents cited potential guiding solutions to improve adherence to pediatric immunization. Top recommendations included:
A deep dive into real-world challenges and ideas for targeted public health strategies.
Visual overview of the most urgent findings from our stakeholder questionnaire.
A summary of what pediatricians can do to improve access and trust in primary care settings.
Aamir Malik is Executive Vice President, Chief U.S. Commercial Officer, Pfizer Inc. Today, he writes about the importance of taking control of your health as you age.

Aamir Malik is Executive Vice President, Chief U.S. Commercial Officer, Pfizer Inc. Today, he writes about the importance of taking control of your health as you age.
Global Health Fellows (GHF) is Pfizer’s signature skills-based volunteering program, empowering colleagues to lend their skills and expertise.

Global Health Fellows (GHF) is Pfizer’s signature skills-based volunteering program, empowering colleagues to lend their skills and expertise.
Learn about the key differences between viral and bacterial infections and the innovative prevention and treatment options being worked on for each type.

Learn about the key differences between viral and bacterial infections and the innovative prevention and treatment options being worked on for each type.
Lyme disease is the most common vector-borne illness in the United States.

Lyme disease is the most common vector-borne illness in the United States.
At Pfizer, we’re driven by our Purpose—to deliver breakthroughs that change patients’ lives.

At Pfizer, we’re driven by our Purpose—to deliver breakthroughs that change patients’ lives.